LifeStance Health Group, Inc.
LFST
$5.49
$0.091.67%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.32B | 1.28B | 1.25B | 1.21B | 1.16B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.32B | 1.28B | 1.25B | 1.21B | 1.16B |
| Cost of Revenue | 888.39M | 866.04M | 848.57M | 829.82M | 804.21M |
| Gross Profit | 428.09M | 417.46M | 402.40M | 376.28M | 352.06M |
| SG&A Expenses | 369.94M | 367.32M | 361.07M | 351.83M | 350.24M |
| Depreciation & Amortization | 57.55M | 62.14M | 70.95M | 78.50M | 83.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.32B | 1.30B | 1.28B | 1.26B | 1.24B |
| Operating Income | 597.00K | -11.99M | -29.62M | -54.05M | -81.19M |
| Income Before Tax | -21.67M | -38.35M | -57.61M | -87.05M | -159.64M |
| Income Tax Expenses | -5.52M | -2.71M | -170.00K | 8.24M | -8.72M |
| Earnings from Continuing Operations | -16.15 | -35.64 | -57.44 | -95.29 | -150.92 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.15M | -35.64M | -57.44M | -95.29M | -150.92M |
| EBIT | 597.00K | -11.99M | -29.62M | -54.05M | -81.19M |
| EBITDA | 58.15M | 50.15M | 41.33M | 24.45M | 1.82M |
| EPS Basic | -0.04 | -0.09 | -0.15 | -0.26 | -0.41 |
| Normalized Basic EPS | -0.03 | -0.06 | -0.09 | -0.13 | -0.17 |
| EPS Diluted | -0.04 | -0.09 | -0.16 | -0.26 | -0.41 |
| Normalized Diluted EPS | -0.03 | -0.06 | -0.09 | -0.13 | -0.17 |
| Average Basic Shares Outstanding | 1.53B | 1.52B | 1.52B | 1.50B | 1.50B |
| Average Diluted Shares Outstanding | 1.54B | 1.53B | 1.52B | 1.50B | 1.50B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |